Article
Inhibition of FLT3 Expression by Green Tea Catechins in FLT3 Mutated-AML Cells
20 Jun 2013
Abstract excerpt
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by a block in differentiation and uncontrolled proliferation. FLT3 is a commonly mutated gene found in AML patients. In clinical trials, the presence of a FLT3-ITD mutation significantly correlates with an increased risk of relapse and dismal overall survival. Therefore, activated FLT3 is a promising molecular target for AML therapies. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
